🚀 VC round data is live in beta, check it out!
Cencora Valuation Multiples
Discover revenue and EBITDA valuation multiples for Cencora and similar public comparables like Grainger, Ferguson, Fastenal, Rheinmetall and more.
Cencora Overview
About Cencora
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Founded
2001
HQ
Employees
51.0K
Website
Sectors
Financials (LTM)
EV
$63B
Cencora Financials
Cencora reported last 12-month revenue of $335B and EBITDA of $5B.
In the same LTM period, Cencora generated $12B in gross profit, $5B in EBITDA, and $3B in net income.
Revenue (LTM)
Cencora P&L
In the most recent fiscal year, Cencora reported revenue of $321B and EBITDA of $4B.
Cencora expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $335B | XXX | $321B | XXX | XXX | XXX |
| Gross Profit | $12B | XXX | $11B | XXX | XXX | XXX |
| Gross Margin | 4% | XXX | 4% | XXX | XXX | XXX |
| EBITDA | $5B | XXX | $4B | XXX | XXX | XXX |
| EBITDA Margin | 2% | XXX | 1% | XXX | XXX | XXX |
| EBIT Margin | 1% | XXX | 1% | XXX | XXX | XXX |
| Net Profit | $3B | XXX | $2B | XXX | XXX | XXX |
| Net Margin | 1% | XXX | 0% | XXX | XXX | XXX |
| Net Debt | — | — | $3B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Cencora Stock Performance
Cencora has current market cap of $60B, and enterprise value of $63B.
Market Cap Evolution
Cencora's stock price is $308.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $63B | $60B | -1.1% | XXX | XXX | XXX | $7.99 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCencora Valuation Multiples
Cencora trades at 0.2x EV/Revenue multiple, and 12.5x EV/EBITDA.
EV / Revenue (LTM)
Cencora Financial Valuation Multiples
As of May 1, 2026, Cencora has market cap of $60B and EV of $63B.
Equity research analysts estimate Cencora's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cencora has a P/E ratio of 18.1x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $60B | XXX | $60B | XXX | XXX | XXX |
| EV (current) | $63B | XXX | $63B | XXX | XXX | XXX |
| EV/Revenue | 0.2x | XXX | 0.2x | XXX | XXX | XXX |
| EV/EBITDA | 12.5x | XXX | 16.9x | XXX | XXX | XXX |
| EV/EBIT | 13.9x | XXX | 16.1x | XXX | XXX | XXX |
| EV/Gross Profit | 5.4x | XXX | 5.5x | XXX | XXX | XXX |
| P/E | 18.1x | XXX | 38.6x | XXX | XXX | XXX |
| EV/FCF | 21.2x | XXX | 19.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cencora Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Cencora Margins & Growth Rates
Cencora's revenue in the last 12 month grew by 7%.
Cencora's revenue per employee in the last FY averaged $6.3M, while opex per employee averaged $0.1M for the same period.
Cencora Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 2% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Growth | 10% | XXX | 8% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $6.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 2% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Cencora Public Comps
See public comps and valuation multiples for other Wholesale Distribution comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Cencora | XXX | XXX | XXX | XXX | XXX | XXX |
| Grainger | XXX | XXX | XXX | XXX | XXX | XXX |
| Ferguson | XXX | XXX | XXX | XXX | XXX | XXX |
| Fastenal | XXX | XXX | XXX | XXX | XXX | XXX |
| Rheinmetall | XXX | XXX | XXX | XXX | XXX | XXX |
| Cardinal Health | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cencora M&A Activity
Cencora acquired XXX companies to date.
Last acquisition by Cencora was on XXXXXXXX, XXXXX. Cencora acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Cencora
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCencora Investment Activity
Cencora invested in XXX companies to date.
Cencora made its latest investment on XXXXXXXX, XXXXX. Cencora invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Cencora
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cencora
| When was Cencora founded? | Cencora was founded in 2001. |
| Where is Cencora headquartered? | Cencora is headquartered in United States. |
| How many employees does Cencora have? | As of today, Cencora has over 51K employees. |
| Who is the CEO of Cencora? | Cencora's CEO is Robert P. Mauch. |
| Is Cencora publicly listed? | Yes, Cencora is a public company listed on NYSE. |
| What is the stock symbol of Cencora? | Cencora trades under COR ticker. |
| When did Cencora go public? | Cencora went public in 1995. |
| Who are competitors of Cencora? | Cencora main competitors are Grainger, Ferguson, Fastenal, Rheinmetall. |
| What is the current market cap of Cencora? | Cencora's current market cap is $60B. |
| What is the current revenue of Cencora? | Cencora's last 12 months revenue is $335B. |
| What is the current revenue growth of Cencora? | Cencora revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Cencora? | Current revenue multiple of Cencora is 0.2x. |
| Is Cencora profitable? | Yes, Cencora is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Cencora? | Cencora's last 12 months EBITDA is $5B. |
| What is Cencora's EBITDA margin? | Cencora's last 12 months EBITDA margin is 2%. |
| What is the current EV/EBITDA multiple of Cencora? | Current EBITDA multiple of Cencora is 12.5x. |
| What is the current FCF of Cencora? | Cencora's last 12 months FCF is $3B. |
| What is Cencora's FCF margin? | Cencora's last 12 months FCF margin is 1%. |
| What is the current EV/FCF multiple of Cencora? | Current FCF multiple of Cencora is 21.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.